Skip to ContentSkip to Navigation
How to find us G. de Vries

Publications

Dual mTORC1/2 inhibition sensitizes testicular cancer models to cisplatin treatment

Establishment and characterisation of testicular cancer patient-derived xenograft models for preclinical evaluation of novel therapeutic strategies

MDM2 inhibitors sensitize testicular cancer models to mTORC1/2 inhibitors and cisplatin

Mechanistic and translational studies to improve cisplatin sensitivity of testicular cancer

Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities: Determinants of cisplatin sensitivity and novel therapeutic opportunities

Read more